Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | University of Dundee |
| Country | United Kingdom |
| Start Date | May 24, 2021 |
| End Date | Oct 01, 2024 |
| Duration | 1,226 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 224010 |
Ubiquitin is a small protein, its addition to other proteins regulates many cellular processes such as protein homeostasis and cell signalling. The addition of ubiquitin to protein substrates is catalysed by an enzymatic cascade. Ubiquitin is transferred from a ubiquitin-activating enzyme (E1) to a ubiquitin conjugating enzyme (E2).
The ubiquitin bound E2 interacts with an E3 ligase which catalyses the transfer of ubiquitin to the substrate. Methods to identify interactions between ubiquitin bound E2s and E3 ligases in cells are limited. To try to capture these interactions I will develop a ubiquitin directed photoreactive probe.
The probe will consist of a photoreactive diazirine group chemically conjugated to recombinant ubiquitin bound to the E2, Ube2W.
The ability of this probe to form covalent attachments with E3 ligases will be validated in vitro using the SUMO-targeted ubiquitin ligase RNF4. Following validation, multiple probes will be made using different E2s.
These will be incubated with cell lysates and irradiated to form photo cross-linked products that will be identified using mass spectrometry.
This approach could potentially identify physiologically relevant E2-E3 pairs and novel E3 ligases which would be beneficial for the development of targeted protein degradation strategies.
University of Dundee
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant